CVE:IPA ImmunoPrecise Antibodies (IPA) Stock Price, News & Analysis → Just Released: Insider's Secret to Trading Options (From Schaeffer’s Research) (Ad) Free IPA Stock Alerts C$6.50 +0.05 (+0.78%) (As of 11/25/2022) Add Compare Share Share Today's RangeC$6.19▼C$6.7050-Day RangeC$6.50▼C$6.5052-Week RangeC$4.52▼C$8.81Volume19,980 shsAverage Volume19,376 shsMarket CapitalizationC$162.08 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get ImmunoPrecise Antibodies alerts: Email Address Ad WealthPress$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…Go here to watch the most recent trading workshop video at no charge. About ImmunoPrecise AntibodiesImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its contract research organization services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multi-species antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing; antibody characterization on label-free biosensors and antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with multiplexed, high-throughput screening, and clone-picking; and cryopreservation. The company has research collaboration agreements with Pierre Fabre S.A for antibody discovery; and Elektrofi, Inc. to explore a high-concentration formulation of COVID-19 antibody cocktail, PolyTope TATX-03. ImmunoPrecise Antibodies Ltd. was incorporated in 1983 and is based in Victoria, Canada.Read More IPA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IPA Stock News HeadlinesMarch 14, 2024 | finance.yahoo.comIPA Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024*December 7, 2023 | finanznachrichten.deImmunoPrecise Antibodies Ltd.: ImmunoPrecise Antibodies Welcomes Mitch Levine To Its Board Of Directors, To Announce Quarterly Results On December 14April 25, 2024 | WealthPress (Ad)$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…November 13, 2023 | benzinga.comBioStrand® Unveils a Revolutionary Approach to Biological Sequence Retrieval: A Fusion of Natural Language Processing and Database ResearchNovember 13, 2023 | msn.comEXCLUSIVE: Antibody-Discovery Platform Provider ImmunoPrecise's Subsidiary Highlights Approach to Biological Sequence RetrievalOctober 23, 2023 | finance.yahoo.comIPA Provides Update on Growth Strategy and Recent Share Price MovementOctober 11, 2023 | finance.yahoo.comImmunoPrecise Antibodies Ltd. (IPA) Could Find a Support Soon, Here's Why You Should Buy the Stock NowAugust 26, 2023 | finance.yahoo.comImmunoPrecise Antibodies Ltd. (TQB.F)April 25, 2024 | WealthPress (Ad)$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…July 13, 2023 | finance.yahoo.comImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q4 2023 Earnings Call TranscriptJuly 12, 2023 | msn.comBenchmark Reiterates ImmunoPrecise Antibodies (IPA) Speculative Buy RecommendationMay 17, 2023 | benzinga.comImmunoPrecise Antibodies Stock (NASDAQ:IPA), Guidance and ForecastMarch 21, 2023 | hk.finance.yahoo.comImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q3 2023 Earnings Call TranscriptMarch 16, 2023 | finance.yahoo.comImmunoPrecise Antibodies Ltd. (IPA) Reports Q3 Loss, Lags Revenue EstimatesMarch 15, 2023 | msn.comEarnings Outlook For ImmunoPrecise AntibodiesSeptember 16, 2022 | finance.yahoo.comHere's Why We're Watching ImmunoPrecise Antibodies' (CVE:IPA) Cash Burn SituationSeptember 16, 2022 | stockhouse.comNIAID Confirms IPA's PolyTope TATX-03 Neutralizing Activity Against the Currently Spreading SARS-CoV-2 Variant BA.2.75September 16, 2022 | seekingalpha.comImmunoPrecise Antibodies Ltd. (IPA) Q1 2023 Earnings Call TranscriptSeptember 14, 2022 | nz.finance.yahoo.comNIAID Confirms IPA’s PolyTope TATX-03 Neutralizing Activity Against the Currently Spreading SARS-CoV-2 Variant BA.2.75August 30, 2022 | stockhouse.comLive Virus Assays at Ludwig-Maximilians-Universität München Confirm PolyTope's Efficacy Against SARS-CoV-2 Variants Including BA.5April 20, 2022 | seekingalpha.comImmunoPrecise antibody cocktail shows neutralizing activity versus Omicron BA.2 in lab testMarch 17, 2022 | seekingalpha.comImmunoPrecise Antibodies reports Q3 resultsDecember 20, 2021 | yahoo.comImmunoPrecise Antibodies and ChemPartner Biologics Announce PolyTope® TATX-03 Antibody Cocktail Manufacturing CollaborationNovember 30, 2021 | finance.yahoo.comImmunoPrecise Update on its SARS-CoV-2 PolyTope™ Multi-Antibody Cocktail Development ProgramSeptember 7, 2021 | stockhouse.comImmunoPrecise Announces Participation at the H.C. Wainwright 23nd Annual Global Investment Conference on September 13-15, 2021 (Virtual Conference)August 4, 2021 | benzinga.comUnusual Options Activity Insight: ImmunoPrecise AntibodiesJuly 28, 2021 | stockhouse.comImmunoPrecise Reports Financial Results and Recent Business Highlights for Full Fiscal Year 2021See More Headlines Receive IPA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ImmunoPrecise Antibodies and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolCVE:IPA CUSIPN/A CIKN/A Webimmunoprecise.com Phone+1-604-8060626FaxN/AEmployees73Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio1.70 Current Ratio5.06 Quick Ratio4.29 Sales & Book Value Annual SalesC$19.47 million Price / Sales8.33 Cash FlowC$0.77 per share Price / Cash Flow8.39 Book ValueC$2.67 per share Price / Book2.44Miscellaneous Outstanding Shares24,935,000Free FloatN/AMarket CapC$162.08 million OptionableNot Optionable BetaN/A 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesDr. Jennifer Lynne Bath Ph.D.CEO, Pres & Non-Independent DirectorMr. Brad McConnChief Financial OfficerDr. Ilse RoodinkChief Scientific OfficerMr. David E. OrtonChief Operating OfficerMs. Carla DahlVP of MarketingDr. Barry Neil DuplantisVP of Client RelationsMore ExecutivesKey CompetitorsBriaCell TherapeuticsCVE:BCTSernovaTSE:SVAMedicenna TherapeuticsTSE:MDNAOncolytics BiotechTSE:ONCScythian BiosciencesCVE:SCYBView All Competitors IPA Stock Analysis - Frequently Asked Questions How have IPA shares performed in 2024? ImmunoPrecise Antibodies' stock was trading at C$6.50 at the beginning of the year. Since then, IPA shares have increased by 0.0% and is now trading at C$6.50. View the best growth stocks for 2024 here. What other stocks do shareholders of ImmunoPrecise Antibodies own? Based on aggregate information from My MarketBeat watchlists, some companies that other ImmunoPrecise Antibodies investors own include Alimentation Couche-Tard (ATD.B), Brookfield Renewable Partners (BEP.UN), Brookfield Infrastructure Partners (BIP.UN), Canadian Utilities (CU), Enghouse Systems (ENGH), Intact Financial (IFC), Metro (MRU), Northwest Pipe (NWPX), TrueContext (PFM) and Royal Bank of Canada (RY). How do I buy shares of ImmunoPrecise Antibodies? Shares of IPA stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:IPA) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceFed launches fourth dollar overhaulStansberry ResearchGreat Crypto BullWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmunoPrecise Antibodies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
